These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

488 related articles for article (PubMed ID: 11562312)

  • 1. Peptide-nucleic acids (PNAs): a tool for the development of gene expression modifiers.
    Gambari R
    Curr Pharm Des; 2001 Nov; 7(17):1839-62. PubMed ID: 11562312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biological activity and delivery of peptide nucleic acids (PNA)-DNA chimeras for transcription factor decoy (TFD) pharmacotherapy.
    Gambari R
    Curr Med Chem; 2004 May; 11(10):1253-63. PubMed ID: 15134518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide nucleic acid-DNA decoy chimeras targeting NF-kappaB transcription factors: Induction of apoptosis in human primary osteoclasts.
    Penolazzi L; Borgatti M; Lambertini E; Mischiati C; Finotti A; Romanelli A; Saviano M; Pedone C; Piva R; Gambari R
    Int J Mol Med; 2004 Aug; 14(2):145-52. PubMed ID: 15254756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chiral peptide nucleic acids with a substituent in the N-(2-aminoethy)glycine backbone.
    Sugiyama T; Kittaka A
    Molecules; 2012 Dec; 18(1):287-310. PubMed ID: 23271467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Computational procedures to explain the different biological activity of DNA/DNA, DNA/PNA and PNA/PNA hybrid molecules mimicking NF-kappaB binding sites.
    Saviano M; Romanelli A; Bucci E; Pedone C; Mischiati C; Bianchi N; Feriotto G; Borgatti M; Gambari R
    J Biomol Struct Dyn; 2000 Dec; 18(3):353-62. PubMed ID: 11149512
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short pyrimidine stretches containing mixed base PNAs are versatile tools to induce translation elongation arrest and truncated protein synthesis.
    Sénamaud-Beaufort C; Leforestier E; Saison-Behmoaras TE
    Oligonucleotides; 2003; 13(6):465-78. PubMed ID: 15025913
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antisense properties of peptide nucleic acids.
    Soomets U; Hällbrink M; Langel U
    Front Biosci; 1999 Nov; 4():D782-6. PubMed ID: 10568787
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factor decoy molecules based on a peptide nucleic acid (PNA)-DNA chimera mimicking Sp1 binding sites.
    Borgatti M; Lampronti I; Romanelli A; Pedone C; Saviano M; Bianchi N; Mischiati C; Gambari R
    J Biol Chem; 2003 Feb; 278(9):7500-9. PubMed ID: 12446679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unlocking the potential of chemically modified peptide nucleic acids for RNA-based therapeutics.
    Pradeep SP; Malik S; Slack FJ; Bahal R
    RNA; 2023 Apr; 29(4):434-445. PubMed ID: 36653113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pyrrolidinyl PNA with α/β-Dipeptide Backbone: From Development to Applications.
    Vilaivan T
    Acc Chem Res; 2015 Jun; 48(6):1645-56. PubMed ID: 26022340
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peptide nucleic acids: Advanced tools for biomedical applications.
    Gupta A; Mishra A; Puri N
    J Biotechnol; 2017 Oct; 259():148-159. PubMed ID: 28764969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peptide nucleic acid (PNA): its medical and biotechnical applications and promise for the future.
    Ray A; Nordén B
    FASEB J; 2000 Jun; 14(9):1041-60. PubMed ID: 10834926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peptide nucleic acids: a review on recent patents and technology transfer.
    Gambari R
    Expert Opin Ther Pat; 2014 Mar; 24(3):267-94. PubMed ID: 24405414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide nucleic acids (PNA) and PNA-DNA chimeras: from high binding affinity towards biological function.
    Uhlmann E
    Biol Chem; 1998; 379(8-9):1045-52. PubMed ID: 9792437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of pendant chiral C(γ)-(alkylideneamino/guanidino) cationic side-chains of PNA backbone on hybridization with complementary DNA/RNA and cell permeability.
    Jain DR; Anandi V L; Lahiri M; Ganesh KN
    J Org Chem; 2014 Oct; 79(20):9567-77. PubMed ID: 25221945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The peptide nucleic acids (PNAs): "high-tech" probes for genetic and molecular cytogenetic investigations].
    Pellestor F; Paulasova P; Macek M; Hamamah S
    Med Sci (Paris); 2005; 21(8-9):753-8. PubMed ID: 16115462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peptide nucleic acid conjugates: synthesis, properties and applications.
    Zhilina ZV; Ziemba AJ; Ebbinghaus SW
    Curr Top Med Chem; 2005; 5(12):1119-31. PubMed ID: 16248787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential of Peptide Nucleic Acids in Future Therapeutic Applications.
    Montazersaheb S; Hejazi MS; Nozad Charoudeh H
    Adv Pharm Bull; 2018 Nov; 8(4):551-563. PubMed ID: 30607328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptide Nucleic Acids: Recent Developments in the Synthesis and Backbone Modifications.
    Singh G; Monga V
    Bioorg Chem; 2023 Dec; 141():106860. PubMed ID: 37748328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of gene expression inside cells by peptide nucleic acids: effect of mRNA target sequence, mismatched bases, and PNA length.
    Doyle DF; Braasch DA; Simmons CG; Janowski BA; Corey DR
    Biochemistry; 2001 Jan; 40(1):53-64. PubMed ID: 11141056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.